| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sharp Phillip A is a Director at SYRS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 25,000 | $39.80 | $995,124.76 | -8.0% | |
| Jan 25, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $37.95 | $569,250.00 | -9.6% | |
| Jan 18, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $37.83 | $567,456.00 | -5.0% | |
| Dec 4, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $109.00 | $3,270,000.00 | -17.6% |